Nuvastatic for fatigue in triple-negative breast cancer patients
Part of Cancer, Skin clinical trials.
This trial tests whether Nuvastatic, a natural supplement, can help reduce fatigue in women with triple-negative breast cancer who are about to start chemotherapy. If you have stable or worsening fatigue and meet the other criteria, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 18 to 65 with triple-negative breast cancer that has spread to other parts of the body.
- You are planning to receive at least 4 to 6 cycles of standard chemotherapy.
- You have a tumor that can be seen on a CT scan or MRI and is at least 1 cm in size.
- You feel well enough to be up and about at least half the day (ECOG score 0 to 2).
- Your hemoglobin level (a measure of red blood cells) is stable and at least 9 g/dL.
- You have fatigue that is stable, new, or getting worse, as measured by a standard fatigue questionnaire.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new capsule (Nuvastatic®) added to standard chemotherapy for people with metastatic colorectal cancer. The goal is to see if it helps shrink tumors and improve well-being.
This study tests whether a specially designed vitamin and mineral supplement can help reduce severe tiredness in women while they are receiving chemotherapy for breast cancer. If you are currently in treatment and have bothersome fatigue, this trial may offer a way to feel better.
This trial tests whether a supervised exercise program can help women with triple-negative breast cancer who are receiving chemotherapy. It may help manage side effects and improve well-being during treatment.
This trial tests whether adding a special low-calorie diet (called a fasting-mimicking diet) to standard chemotherapy and immunotherapy can help treat triple-negative breast cancer before surgery. It aims to see if this combination makes the treatment work better.
This study tests an oral supplement (Nuvastatic) to see if it helps reduce fatigue in people with stage IV colon cancer who are starting chemotherapy for the first time. If you are 18–65 and have fatigue that is affecting you, this trial might offer a way to feel better.
This trial tests a wearable device that gently stimulates a nerve in your neck to reduce extreme tiredness caused by immune-boosting cancer treatments. You'll wear it for 4 weeks while continuing your cancer medicine, and researchers will see if it helps you feel less fatigued.
Hear when a new Fatigue Related to Cancer Treatment trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.